Previous Article | Next Article ![]()
Journal of Virology, October 1998, p. 8392-8395, Vol. 72, No. 10
Biochemistry of the Cell Nucleus, Imperial
Cancer Research Fund Laboratories, London WC2A 3PX, United Kingdom
Received 30 March 1998/Accepted 13 July 1998
Constitutive expression of the c-myc proto-oncogene in
growth factor-deprived fibroblasts promotes proliferation and induces apoptosis. In these cells, apoptosis can be inhibited by survival factors such as insulin-like growth factor I or the bcl-2
proto-oncogene product. Deregulated c-Myc expression is a common
feature in Epstein-Barr virus-positive Burkitt's lymphoma in which the
c-myc gene is reciprocally translocated and placed under
the control of one of the immunoglobulin loci. BHRF1 is an Epstein-Barr
virus protein expressed early in the lytic cycle. BHRF1 is a member of
the Bcl-2 family and has been shown to suppress apoptosis and to
increase cell survival in different settings. In the present study, we
report that BHRF1 inhibits c-Myc-induced apoptosis which occurs in the
absence of survival factors. It does not, however, affect the capacity
of c-Myc to promote cell growth. These findings demonstrate that BHRF1
has not only structural but also functional similarities to Bcl-2.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Suppression of c-Myc-Induced Apoptosis by the
Epstein-Barr Virus Gene Product BHRF1
*
Corresponding author. Present address: Onyx
Pharmaceuticals, 3031 Research Dr., Richmond, CA 94806. Phone: (510)
222 9700. Fax: (510) 222 9758. E-mail:
afanidi{at}onyx-pharm.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»